|
OB/GYN Annual Topic
Index 2005
[ Topic | Author ]
Adolescent gynecology
Contemporary management of abnormal uterine bleeding in adolescents. Mar:34-38
Depot medroxyprogesterone acetate injectable contraception in adolescents: reassuring data regarding skeletal health. May:9-10
Menstrual management in adolescents with developmental disabilities. Nov:13-16
Teenagers and sex: delaying sexual debut. Apr:29-38
Update on adolescent contraception. Jun:39-44
back to top
Alternative & complementary medicine
Bio-identical hormones: keys to making an informed decision. Oct(suppl):13-14
Bioidentical hormones: separating science from marketing. Oct:21-22
Depression during pregnancy. Oct:23-30,57
A dietary prescription for menopause and beyond. May:45-50
Endometrial ablation: more choices, more options. Dec:35-40
Hyperlipidemia: nutritional, botanical, and life-style influences. Jan:42-46
Infertility and the mind/body connection. Jul:24-28
back to top
Cancer
Breast cancer risk reduction. Oct:16-20; Oct(suppl):7-9
Cervical cancer screening: a simple screening test that can save your life. Jun(suppl):4-6
Coffee/caffeine consumption and women’s health. May:12-17
Does the progestin in oral combination hormone therapy make a difference: clinical implications. Apr:1-8(newsletter)
Finding gynecologic cancers early: what women need to know. Dec(suppl):7-10
The health benefits of hormonal contraceptives. Apr(suppl):19-24
Human papillomavirus DNA testing in office practice. Apr:17-26
My most memorable moment: despite our best efforts. Dec:24-25
Nonhormonal contraception in women with medical conditions. Nov(suppl):8-12
Postmenopausal hormone therapy: clarifying the role. Feb:53-54
Postmenopausal hormone therapy: where do we go from here? Feb(suppl):11-12
Saline-wash endometrial biopsy: a study examining the effectiveness of cytology as an adjuvant to histology. Mar:22-26
Screening for gynecologic cancer: hope and frustration. Dec:7-8
Screening for gynecologic malignancies of the genital tract. Dec:9-14
Staging and adjuvant therapy for endometrial cancer. May:18-26
back to top
Cardiovascular disorders
Cardiac risk prediction in patients undergoing gynecologic surgery. Jan:15-21
Coffee/caffeine consumption and women’s health. May:12-17
Combination oral contraceptives and migraine: is there an increased risk for ischemic stroke? Apr:50-56
Does the progestin in oral combination hormone therapy make a difference: clinical implications. Apr:1-8(newsletter)
Heart disease in women: knowing the risks, recognizing the symptoms. Feb(suppl):5-7
Hyperlipidemia: nutritional, botanical, and life-style influences. Jan:42-46
Nonhormonal contraception in women with medical conditions. Nov(suppl):8-12
Postmenopausal hormone therapy: clarifying the role. Feb:53-54
Postmenopausal hormone therapy: where do we go from here? Feb(suppl):11-12
Recognizing hypertensive disorders and eclampsia in pregnancy. Feb:12-17,52
back to top
Chemotherapy
Staging and adjuvant therapy for endometrial cancer. May:18-26
back to top
Coagulation disorders
Contemporary management of abnormal uterine bleeding in adolescents. Mar:34-38
back to top
Computed tomography
Adnexal mass in pregnancy. Mar:39-40
back to top
Continuing medical education (CME)
Abnormal uterine bleeding. Sep:44-50[test 51-52]
Anesthetic issues and complications related to laparoscopic surgery. Jul:37-42[test 43-44]
Counseling techniques for contraceptive success. Apr(suppl):11-14[test 31-32]
Diabetes in pregnancy. Apr:40-49[test 71-72]
Diagnosing migraine aura. Oct:45-50[test 51-52]
The effects of contraception on the vaginal ecosystem. Apr(suppl):25-30[test 31-32]
Endometrial ablation: more choices, more options. Dec:35-40[test 41-42]
The health benefits of hormonal contraceptives. Apr(suppl):19-24[test 31-32]
Hormone therapy and Alzheimer disease: an evidence-based approach to clinical management. Jan:9-14 [test 47-48]
Introduction: contraception doesn’t work if you don’t use it. Apr(suppl):3-5[test 31-32]
Menopausal hormone therapy: the symptomatic patient. Mar:16-21[test 41-42]
Nonoral contraception: improved compliance with newer hormonal methods. Apr(suppl):6-10[test 31-32]
Pharmacologic treatment of overactive bladder: review and comparison. Feb:22-27[test 55-56]
Premenopausal osteoporosis. Nov:40-46[test 47-48]
Sexually transmitted infections in women: an overview. Aug:51-56[test 57-58]
Update on vulvovaginal candidiasis. May:36-42[test 43-44]
Vulvodynia. Jun:48-54[test 55-56]
What you should know about today’s hormonal contraceptive options. Apr(suppl):15-18[test 31-32]
back to top
Contraception and contraceptives
Abnormal uterine bleeding. Sep:44-50
Another contraceptive choice: the single-rod implant. Feb:46-52
Are you looking for a nonhormonal contraceptive? Nov(suppl):13-16
The benefits of intrauterine devices over sterilization. Nov(suppl):24-28
Combination oral contraceptives and migraines: an increased risk for stroke? Jun(suppl):11-13
Combination oral contraceptives and migraine: is there an increased risk for ischemic stroke? Apr:50-56
Contraception and insurance coverage. Feb(suppl):14-16
Contraception in the perimenopausal woman. Aug:41-45
Contraceptive counseling can impact contraceptive success. Aug(suppl):3
Counseling strategies to lead patients to successful contraceptive choices. Aug(suppl):4-6
Counseling techniques for contraceptive success. Apr(suppl):11-14
Depot medroxyprogesterone acetate injectable contraception in adolescents: reassuring data regarding skeletal health. May:9-10
Educating tomorrow’s physicians in reproductive health. Dec:26-28
The effects of contraception on the vaginal ecosystem. Apr(suppl):25-30
Emergency contraception: telling the secret. Jan:22-23,27-28
Estrogen withdrawal effects associated with combined oral contraceptives. Sep:21-26
Expanded patient profile and today’s intrauterine device. Nov(suppl):3-7
Family planning for obese women: challenges and opportunities. Oct:34,39-41
Fertility changes during perimenopause. Dec:22-23
Fertility changes, perimenopause, and menopause. Dec(suppl):13-14
The health benefits of hormonal contraceptives. Apr(suppl):19-24
Introduction: contraception doesn’t work if you don’t use it. Apr(suppl):3-5
Menstrual management in adolescents with developmental disabilities. Nov:13-16
Nonhormonal contraception in women with medical conditions. Nov(suppl):8-12
Nonoral contraception: improved compliance with newer hormonal methods. Apr(suppl):6-10
Nonhormonal contraception: risks and benefits—helping women make the right choice. Nov(suppl):23
Oral contraceptive use in women with migraine. Aug:32-38
Oral contraceptives: impact of perceived weight changes. Jul:12-16,23
Research in male contraception. Jun:33-36
Streamlining the review of contraceptive options. Aug(suppl):11-15
Update on adolescent contraception. Jun:39-44
What you should know about today’s hormonal contraceptive options. Apr(suppl):15-18
Working together to facilitate contraceptive success. Aug(suppl):16
back to top
Counseling
Contraceptive counseling can impact contraceptive success. Aug(suppl):3
Counseling strategies to lead patients to successful contraceptive choices. Aug(suppl):4-6
Counseling techniques for contraceptive success. Apr(suppl):11-14
Neonatal decision-making: provision of life support at the threshold of viability. Aug:10-12,17-20
Nonhormonal contraception: risks and benefits—helping women make the right choice. Nov(suppl):23
Streamlining the review of contraceptive options. Aug(suppl):11-15
Working together to facilitate contraceptive success. Aug(suppl):16
back to top
Diabetes
Coffee/caffeine consumption and women’s health. May:12-17
Diabetes in pregnancy. Apr:40-49
Nonhormonal contraception in women with medical conditions. Nov(suppl):8-12
Update on vulvovaginal candidiasis. May:36-42
When diabetes hurts: the pain of diabetic neuropathy. Oct(suppl):10-12
back to top
Diagnostic guidelines/tools
Diagnosing migraine aura. Oct:45-50
Living with interstitial cystitis. Apr(suppl):14-18
Pelvic pain and urgency/frequency patient symptom scale. Apr(suppl):9
Update on vulvovaginal candidiasis. May:36-42
back to top
Eating disorders
The female athlete triad: three conditions that can threaten the health of girls and women who “get in the game.” Feb(suppl):8-10
back to top
Editorials
At least Gregor Samsa knew he was an insect: a survival guide for physicians who care for female patients. Aug:8-9
The case for preimplantation genetic diagnosis. Mar:10,33
Depot medroxyprogesterone acetate injectable contraception in adolescents: reassuring data regarding skeletal health. May:9-10
Four resolutions. Jan:7-8
Lessons learned from the hammer and the nail. Nov:10-12
Liability reform should be an access issue, not a money issue. Apr:15-16
The obesity epidemic: it’s spreading. Feb:11
Polypharmacy: plague or panacea? Oct:7-8
Quality health care under assault. Sep:10-11
Reproductive rights. Jul:10-11
Screening for gynecologic cancer: hope and frustration. Dec:7-8
Why won’t patients do what they’re told? Jun:10-11
back to top
Endocrinologic disorders
Thyroid disease in women. Dec(suppl):4-6
back to top
Epilepsy
Nonhormonal contraception in women with medical conditions. Nov(suppl):8-12
back to top
Exercise
Exercise: an elixir for osteoporosis prevention. Jun(suppl):9-10
back to top
Evidence-based medicine/approaches
Four resolutions. Jan:7-8
Hormone therapy and Alzheimer disease: an evidence-based approach to clinical management. Jan:9-14
Nonsurgical management of a large hemoperitoneum from a ruptured corpus luteum: a 15-year study. Nov:29-34
back to top
Gastrointestinal disorders
Serotonergic agents in the treatment of irritable bowel syndrome: a safety review. Sep:30-34
Treating irritable bowel syndrome: an overview of new options. Oct(suppl):4-6
back to top
Gender issues
Gender differences in nicotine and alcohol dependence. Dec:30-33
back to top
Genetics
The case for preimplantation genetic diagnosis. Mar:10,33
Ethics: an essential dimension of first-trimester risk assessment for trisomy 21. Nov:21-24
Human papillomavirus DNA testing in office practice. Apr:17-26
My most memorable moment: despite our best efforts. Dec:24-25
back to top
Gynecologic disorders
Sacral nerve stimulation for pelvic floor disorders. Jan:36-40
Spontaneous transvaginal evisceration of the small bowel. Oct:32-33
Urethral diverticula: a review of evaluation and management. Jul:17-23
Vaginal atrophy: clinical evaluation and management. Apr:65-66
Vaginal dryness and atrophy. Aug(suppl):4,13
Vulvodynia. Jun:48-54
back to top
Headache
Combination oral contraceptives and migraines: an increased risk for stroke? Jun(suppl):11-13
Combination oral contraceptives and migraine: is there an increased risk for ischemic stroke? Apr:50-56
Diagnosing migraine aura. Oct:45-50
Estrogen withdrawal effects associated with combined oral contraceptives. Sep:21-26
Oral contraceptive use in women with migraine. Aug:32-38
Nonhormonal contraception in women with medical conditions. Nov(suppl):8-12
back to top
Health insurance
Contraception and insurance coverage. Feb(suppl):14-16
back to top
Hematologic disorders
Postpartum hemorrhage in the developed world: an enigma. Dec:17-21
back to top
Hormone therapy
Abnormal uterine bleeding. Sep:44-50
Bio-identical hormones: keys to making an informed decision. Oct(suppl):13-14
Bioidentical hormones: separating science from marketing. Oct:21-22
Contemporary management of abnormal uterine bleeding in adolescents. Mar:34-38
Depot medroxyprogesterone acetate injectable contraception in adolescents: reassuring data regarding skeletal health. May:9-10
Does the progestin in oral combination hormone therapy make a difference: clinical implications. Apr:1-8(newsletter)
Estrogen withdrawal effects associated with combined oral contraceptives. Sep:21-26
Hormone therapy and Alzheimer disease: an evidence-based approach to clinical management. Jan:9-14
Hormone therapy for the postmenopausal woman: balancing benefits versus risks. Jun:1-8: (newsletter)
Memory complaints. Aug:39-40
Menopausal hormone therapy: the symptomatic patient. Mar:16-21
Menstrual management in adolescents with developmental disabilities. Nov:13-16
Postmenopausal hormone therapy: clarifying the role. Feb:53-54
Postmenopausal hormone therapy: where do we go from here? Feb(suppl):11-12
Staging and adjuvant therapy for endometrial cancer. May:18-26
Vaginal atrophy: clinical evaluation and management. Apr:65-66
Vaginal dryness and atrophy. Aug(suppl):4,13
back to top
Infections
The effects of contraception on the vaginal ecosystem. Apr(suppl):25-30
Human papillomavirus DNA testing in office practice. Apr:17-26
Update on vulvovaginal candidiasis. May:36-42
back to top
Infertility
Infertility and the mind/body connection. Jul:24-28
back to top
Laparoscopy
Anesthetic issues and complications related to laparoscopic surgery. Jul:37-42
Laparoscopy in the obese gynecologic patient. Jan:29-35
Nonsurgical management of a large hemoperitoneum from a ruptured corpus luteum: a 15-year study. Nov:29-34
The pros and cons of laparoscopic hysterectomy. Mar:27-33
back to top
Laparotomy
Nonsurgical management of a large hemoperitoneum from a ruptured corpus luteum: a 15-year study. Nov:29-34
back to top
Laser therapy
Endoluminal varicose vein therapy. Jun:22-29,32
Endometrial ablation: more choices, more options. Dec:35-40
back to top
Prenatal screeningMagnetic resonance imaging
Misleading urogenital anomaly. Nov:49-50
Placenta percreta diagnosed antenatally with magnetic resonance imaging. Sep:37-39
back to top
Medical coding
Abnormal uterine bleeding. Sep:44-50
Depression during pregnancy. Oct:23-30,57
Premenopausal osteoporosis. Nov:40-46
Prenatal testing for Down syndrome. Jun:12-21
Screening for gynecologic malignancies of the genital tract. Dec:9-14
Sexually transmitted infections in women: an overview. Aug:51-56
Update on vulvovaginal candidiasis. May:36-42
back to top
Medical training
Educating tomorrow’s physicians in reproductive health. Dec:26-28
back to top
Menopause
Abnormal uterine bleeding. Sep:44-50
Bio-identical hormones: keys to making an informed decision. Oct(suppl):13-14
Bioidentical hormones: separating science from marketing. Oct:21-22
Bisphosphonate dosing preferences in women with postmenopausal osteoporosis: a study. Jul:31-36
Contraception in the perimenopausal woman. Aug:41-45
A dietary prescription for menopause and beyond. May:45-50
Does the progestin in oral combination hormone therapy make a difference: clinical implications. Apr:1-8(newsletter)
Fertility changes during perimenopause. Dec:22-23
Fertility changes, perimenopause, and menopause. Dec(suppl):13-14
Fractures and falls: minimizing the risks. Jun:45-46
Hormone therapy and Alzheimer disease: an evidence-based approach to clinical management. Jan:9-14
Hormone therapy for the postmenopausal woman: balancing benefits versus risks. Jun:1-8(newsletter)
Loss of sexual desire and menopause: prevalence, causes, and impact on quality of life. Apr:57-63
Memory complaints. Aug:39-40
Menopausal hormone therapy: the symptomatic patient. Mar:16-21
The need for early recognition and treatment of osteoporosis to prevent fractures. Feb:34-44
Osteoporotic fractures and falls: reducing the risk. Jun(suppl):7-8
Postmenopausal hormone therapy: clarifying the role. Feb:53-54
Postmenopausal hormone therapy: where do we go from here? Feb(suppl):11-12
Premenopausal osteoporosis. Nov:40-46
Vaginal atrophy: clinical evaluation and management. Apr:65-66
Vaginal dryness and atrophy. Aug(suppl):4,13
back to top
Menstruation
Abnormal uterine bleeding. Sep:44-50
Contemporary management of abnormal uterine bleeding in adolescents. Mar:34-38
The effects of contraception on the vaginal ecosystem. Apr(suppl):25-30
Endometrial ablation: more choices, more options. Dec:35-40
Estrogen withdrawal effects associated with combined oral contraceptives. Sep:21-26
The female athlete triad: three conditions that can threaten the health of girls and women who “get in the game.” Feb(suppl):8-10
The health benefits of hormonal contraceptives. Apr(suppl):19-24
Lessons from the Olympic road: I left a part of myself on the finish line. Feb(suppl):2-4
Menstrual management in adolescents with developmental disabilities. Nov:13-16
Premenopausal osteoporosis. Nov:40-46
back to top
Neonatal care
Brachial plexus injury: the role of shoulder dystocia. Sep:12-16
Neonatal decision-making: provision of life support at the threshold of viability. Aug:10-12,17-20
back to top
Neurologic disorders
Diagnosing migraine aura. Oct:45-50
Fetal alcohol syndrome: a continuing challenge. Sep:40-43
Hormone therapy and Alzheimer disease: an evidence-based approach to clinical management. Jan:9-14
Neonatal decision-making: provision of life support at the threshold of viability. Aug:10-12,17-20
Nonhormonal contraception in women with medical conditions. Nov(suppl):8-12
back to top
Nutrition
Calcium supplements: some extra protection for your bone bank. Dec(suppl):11-12
Coffee/caffeine consumption and women’s health. May:12-17
A dietary prescription for menopause and beyond. May:45-50
Food label lingo. Aug(suppl):14
Hyperlipidemia: nutritional, botanical, and life-style influences. Jan:42-46
Living with interstitial cystitis. Apr(suppl):14-18
Premenopausal osteoporosis. Nov:40-46
Slim down recipes to save calories and fat. Jun(suppl):14
back to top
Obesity
Family planning for obese women: challenges and opportunities. Oct:34,39-41
The health benefits of hormonal contraceptives. Apr(suppl):19-24
Laparoscopy in the obese gynecologic patient. Jan:29-35
Nonhormonal contraception in women with medical conditions. Nov(suppl):8-12
The obesity epidemic: it’s spreading. Feb:11
back to top
Osteoporosis
Bisphosphonate dosing preferences in women with postmenopausal osteoporosis: a study. Jul:31-36
Calcium supplements: some extra protection for your bone bank. Dec(suppl):11-12
Does the progestin in oral combination hormone therapy make a difference: clinical implications. Apr:1-8(newsletter)
Exercise: an elixir for osteoporosis prevention. Jun(suppl):9-10
The female athlete triad: three conditions that can threaten the health of girls and women who “get in the game.” Feb(suppl):8-10
Fractures and falls: minimizing the risks. Jun:45-46
Lessons from the Olympic road: I left a part of myself on the finish line. Feb(suppl):2-4
The need for early recognition and treatment of osteoporosis to prevent fractures. Feb:34-44
Osteoporotic fractures and falls: reducing the risk. Jun(suppl):7-8
Postmenopausal hormone therapy: clarifying the role. Feb:53-54
Postmenopausal hormone therapy: where do we go from here? Feb(suppl):11-12
Premenopausal osteoporosis. Nov:40-46
back to top
Pain
Interstitial cystitis: one woman’s story. Apr(suppl):2-4
Interstitial cystitis: why it’s so tricky to diagnose. Apr(suppl):10-12
Living with interstitial cystitis. Apr(suppl):14-18
Recurrent clitoral pain and drainage. Jul:29-30
Vulvodynia. Jun:48-54
What is interstitial cystitis? Apr(suppl):5-8
When diabetes hurts: the pain of diabetic neuropathy. Oct(suppl):10-12
back to top
Patient education
Are you looking for a nonhormonal contraceptive? Nov(suppl):13-16
Cervical cancer screening: a simple screening test that can save your life. Jun(suppl):4-6
Combination oral contraceptives and migraines: an increased risk for stroke? Jun(suppl):11-13
Exercise: an elixir for osteoporosis prevention. Jun(suppl):9-10
Living with interstitial cystitis. Apr(suppl):14-18
Interstitial cystitis check list. Apr(suppl):13
Interstitial cystitis: why it’s so tricky to diagnose. Apr(suppl):10-12
Living with interstitial cystitis. Apr(suppl):14-18
Osteoporotic fractures and falls: reducing the risk. Jun(suppl):7-8
Pelvic pain and urgency/frequency patient symptom scale. Apr(suppl):9
Slim down recipes to save calories and fat. Jun(suppl):14
What is interstitial cystitis? Apr(suppl):5-8
What you should know about today’s hormonal contraceptive options. Apr(suppl):15-18
What you should know about…
Abnormal uterine bleeding. Sep:53-54
Alzheimer’s disease. Jan:49-50
Breast cancer. Oct:53-54
Diet and menopause. Jun:57-58
Endometrial ablation. Dec:43-44
Hysterectomy. Mar:43-44
Infertility and the mind/body connection. Jul:45-46
Menopause and sexual desire. Apr:67-68
Overactive bladder. Feb:57-58
Premenopausal osteoporosis. Nov:51-52
Sexually transmitted infections. Aug:47-48
Yeast infections. May:51-52
back to top
Pharmacotherapy
Adnexal mass in pregnancy. Mar:39-40
Bio-identical hormones: keys to making an informed decision. Oct(suppl):13-14
Bioidentical hormones: separating science from marketing. Oct:21-22
Bisphosphonate dosing preferences in women with postmenopausal osteoporosis: a study. Jul:31-36
Breast cancer risk reduction. Oct:16-20; Oct(suppl):7-9
Depression during pregnancy. Oct:23-30,57
Interstitial cystitis: one woman’s story. Apr(suppl):2-4
Living with interstitial cystitis. Apr(suppl):14-18
The need for early recognition and treatment of osteoporosis to prevent fractures. Feb:34-44
Pharmacologic treatment of overactive bladder: review and comparison. Feb:22-27
Polypharmacy: plague or panacea? Oct:7-8
Recognizing hypertensive disorders and eclampsia in pregnancy. Feb:12-17,52
The schizophrenic patient: the reproductive years and beyond. Aug:22-31
Serotonergic agents in the treatment of irritable bowel syndrome: a safety review. Sep:30-34
Treating irritable bowel syndrome: an overview of new options. Oct(suppl):4-6
back to top
Pregnancy
The case for preimplantation genetic diagnosis. Mar:10,33
Coffee/caffeine consumption and women’s health. May:12-17
Depression during pregnancy. Oct:23-30,57
Diabetes in pregnancy. Apr:40-49
Ethics: an essential dimension of first-trimester risk assessment for trisomy 21. Nov:21-24
Family planning for obese women: challenges and opportunities. Oct:34,39-41
Fetal alcohol syndrome: a continuing challenge. Sep:40-43
Introduction: contraception doesn’t work if you don’t use it. Apr(suppl):3-5
Placenta percreta diagnosed antenatally with magnetic resonance imaging. Sep:37-39
Postpartum hemorrhage in the developed world: an enigma. Dec:17-21
Predicting preterm births in high-risk patients. Oct:10-13
Prenatal testing for Down syndrome. Jun:12-21
Recognizing hypertensive disorders and eclampsia in pregnancy. Feb:12-17,52
The schizophrenic patient: the reproductive years and beyond. Aug:22-31
Teenagers and sex: delaying sexual debut. Apr:29-38
Thyroid disease in women. Dec(suppl):4-6
Treatment of failed cephalic replacement after shoulder dystocia. Jun:30-32
Triplets: update on obstetric considerations. Mar:11-14
back to top
Psychiatric disorders
Depression during pregnancy. Oct:23-30,57
The schizophrenic patient: the reproductive years and beyond. Aug:22-31
back to top
Psychological issues
Domestic violence: your doctor may be able to help. Aug(suppl):5-6,12
Infertility and the mind/body connection. Jul:24-28
Living with interstitial cystitis. Apr(suppl):14-18
Loss of sexual desire and menopause: prevalence, causes, and impact on quality of life. Apr:57-63
Memory complaints. Aug:39-40
back to top
Pulmonary disorders
The case for preimplantation genetic diagnosis. Mar:10,33
back to top
Regulatory/Reform issues
At least Gregor Samsa knew he was an insect: a survival guide for physicians who care for female patients. Aug:8-9
Four resolutions. Jan:7-8
Liability reform should be an access issue, not a money issue. Apr:15-16
Reproductive rights. Jul:10-11
back to top
Screening/Guidelines
Cardiac risk prediction in patients undergoing gynecologic surgery. Jan:15-21
The case for preimplantation genetic diagnosis. Mar:10,33
Cervical cancer screening: a simple screening test that can save your life. Jun(suppl):4-6
Domestic violence: your doctor may be able to help. Aug(suppl):5-6,12
Fetal alcohol syndrome: a continuing challenge. Sep:40-43
Finding gynecologic cancers early: what women need to know. Dec(suppl):7-10
Human papillomavirus DNA testing in office practice. Apr:17-26
Oral contraceptive use in women with migraine. Aug:32-38
Polypharmacy: plague or panacea? Oct:7-8
Prenatal testing for Down syndrome. Jun:12-21
Screening for gynecologic cancer: hope and frustration. Dec:7-8
Screening for gynecologic malignancies of the genital tract. Dec:9-14
Screening patients for nonadherence. Feb:28-33
Sexually transmitted infections in women: an overview. Aug:51-56
back to top
Sexual health
Domestic violence: your doctor may be able to help. Aug(suppl):5-6,12
Loss of sexual desire and menopause: prevalence, causes, and impact on quality of life. Apr:57-63
Teenagers and sex: delaying sexual debut. Apr:29-38
back to top
Sexually transmitted infections (STIs)
The effects of contraception on the vaginal ecosystem. Apr(suppl):25-30
The health benefits of hormonal contraceptives. Apr(suppl):19-24
Human papillomavirus DNA testing in office practice. Apr:17-26
Sexually transmitted infections in women: an overview. Aug:51-56
Teenagers and sex: delaying sexual debut. Apr:29-38
back to top
Substance abuse
Gender differences in nicotine and alcohol dependence. Dec:30-33
back to top
Surgery
Abnormal uterine bleeding. Sep:44-50
Anesthetic issues and complications related to laparoscopic surgery. Jul:37-42
Breast cancer risk reduction. Oct:16-20; Oct(suppl):7-9
Cardiac risk prediction in patients undergoing gynecologic surgery. Jan:15-21
Laparoscopy in the obese gynecologic patient. Jan:29-35
Living with interstitial cystitis. Apr(suppl):14-18
My most memorable moment: despite our best efforts. Dec:24-25
Nonsurgical management of a large hemoperitoneum from a ruptured corpus luteum: a 15-year study. Nov:29-34
Obliterative vaginal surgery for the treatment of advanced pelvic organ prolapse. May:28-34
Placenta percreta diagnosed antenatally with magnetic resonance imaging. Sep:37-39
Predicting preterm births in high-risk patients. Oct:10-13
The pros and cons of laparoscopic hysterectomy. Mar:27-33
Recurrent clitoral pain and drainage. Jul:29-30
Sacral nerve stimulation for pelvic floor disorders. Jan:36-40
Spontaneous transvaginal evisceration of the small bowel. Oct:32-33
Staging and adjuvant therapy for endometrial cancer. May:18-26
Treatment of failed cephalic replacement after shoulder dystocia. Jun:30-32
Urethral diverticula: a review of evaluation and management. Jul:17-23
back to top
Ultrasonography
Adnexal mass in pregnancy. Mar:39-40
Endoluminal varicose vein therapy. Jun:22-29,32
Misleading urogenital anomaly. Nov:49-50
Nonsurgical management of a large hemoperitoneum from a ruptured corpus luteum: a 15-year study. Nov:29-34
Placenta percreta diagnosed antenatally with magnetic resonance imaging. Sep:37-39
Predicting preterm births in high-risk patients. Oct:10-13
back to top
Urogynecology
Interstitial cystitis: one woman’s story. Apr(suppl):2-4
Obliterative vaginal surgery for the treatment of advanced pelvic organ prolapse. May:28-34
Pharmacologic treatment of overactive bladder: review and comparison. Feb:22-27
Sacral nerve stimulation for pelvic floor disorders. Jan:36-40
Urethral diverticula: a review of evaluation and management. Jul:17-23
What is interstitial cystitis? Apr(suppl):5-8
back to top
Urologic disorders
Abnormal uterine bleeding. Sep:44-50
Interstitial cystitis: why it’s so tricky to diagnose. Apr(suppl):10-12
Living with interstitial cystitis. Apr(suppl):14-18
Olympic idol Mary Lou Retton opens up about overactive bladder. Aug(suppl):7-10
Pharmacologic treatment of overactive bladder: review and comparison. Feb:22-27
Sacral nerve stimulation for pelvic floor disorders. Jan:36-40
What is interstitial cystitis? Apr(suppl):5-8
back to top
|
